Search results
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation - Regeneron ...
Benzinga· 41 minutes agoOn Thursday, Regeneron Pharmaceuticals Inc REGN reported first-quarter adjusted EPS of $9.55, down...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 8 hours agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 27 minutes agoThe high dose is a new formulation with a longer patent life — a key development with standard Eylea...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 6 hours agoRegeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due to...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 8 hours agoResearch and Development: R&D expenses increased by 13% to $1.248 billion, reflecting ongoing...
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
Market Watch· 10 hours agoBy Denny Jacob Regeneron Pharmaceuticals posted lower-than-expected revenue in its latest quarter which resulted in part from lower sales of EYLEA in the...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 9 hours agoWith that as a backdrop, here are three biotech stocks that are worth holding for years to come:...
Checking in on Regeneron Pharmaceuticals, Inc.
Knox Daily· 1 day agoRegeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr 01 ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 10 hours ago(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly...
Regeneron Falls On Earnings Miss
Investor's Business Daily· 10 hours agoThe biotech giant's earnings and sales both missed Q1 estimates.